• Blueberry Therapeutics bags £10M to push dermatology nanomedicines fiercebiotech
    August 16, 2018
    Athlete’s foot and fungal nail infections aren’t the types of diseases that tend to get investors’ hearts pumping, but that’s not stopping Blueberry Therapeutics. The U.K.-based startup reeled in £10 million ($12.7 million) in series B funding that will,
PharmaSources Customer Service